Document is current
Any future updates will be listed below
-
Authors
Thomsen, Soren K. https://orcid.org/0000-0001-8894-2868
Raimondo, Anne
Hastoy, Benoit https://orcid.org/0000-0003-1244-7857
Sengupta, Shahana https://orcid.org/0000-0003-2996-7971
Dai, Xiao-Qing
Bautista, Austin
Censin, Jenny https://orcid.org/0000-0001-6625-6074
Payne, Anthony J.
Umapathysivam, Mahesh M.
Spigelman, Aliya F.
Barrett, Amy
Groves, Christopher J.
Beer, Nicola L.
Manning Fox, Jocelyn E.
McCarthy, Mark I. https://orcid.org/0000-0002-4393-0510
Clark, Anne
Mahajan, Anubha https://orcid.org/0000-0001-5585-3420
Rorsman, Patrik
MacDonald, Patrick E.
Gloyn, Anna L. https://orcid.org/0000-0003-1205-1844
- License Information
-
More Information
Article History
Received: 21 September 2017
Accepted: 6 June 2018
First Online: 27 July 2018
Competing interests
: S.K.T. is now an employee of Vertex Pharmaceuticals, and N.L.B. is now an employee of Novo Nordisk, although all experimental work was carried out under employment at the University of Oxford. A.L.G. has received research funding and honoraria from Novo Nordisk. M.I.M. serves on advisory panels for Pfizer, Novo Nordisk and Zoe Global; has received honoraria from Pfizer, Novo Nordisk and Eli Lilly; has stock options in Zoe Global; and has received research funding from AbbVie, Astra Zeneca, Boehringer Ingelheim, Eli Lilly, Janssen, Merck, Novo Nordisk, Pfizer, Roche, Sanofi Aventis, Servier and Takeda.
